Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Earth Life Sciences (OTCPK:CLTS) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Earth Life Sciences Equity-to-Asset Related Terms
Earth Life Sciences Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Earth Life Sciences's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CLTS vs IMCI, CRCW, SSFT: Equity-to-Asset Comparison
For the Information Technology Services subindustry, Earth Life Sciences's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Earth Life Sciences Equity-to-Asset vs Software Industry
For the Software industry and Technology sector, Earth Life Sciences's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Earth Life Sciences's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Earth Life Sciences's Equity to Asset Ratio for the fiscal year that ended in Dec. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Earth Life Sciences (CLTS) has a Equity-to-Asset of 0.91 as of Sep. 2022. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Earth Life Sciences and its competitors.
Is Earth Life Sciences' Equity-to-Asset too high?
Earth Life Sciences' current Equity-to-Asset is 0.91. The Software industry median Equity-to-Asset is 0.55. Earth Life Sciences' value of 0.91 is 65.5% above this industry median. Overall, Earth Life Sciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Earth Life Sciences' Equity-to-Asset compare to IMCI and CRCW?
Earth Life Sciences' Equity-to-Asset of 0.91 can be compared against companies in the Software industry. The industry median Equity-to-Asset is 0.55. Earth Life Sciences' value of 0.91 is 65.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Software company?
The median Equity-to-Asset among Software companies is 0.55, based on 2,891 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Earth Life Sciences's current Equity-to-Asset of 0.91 is 65.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Earth Life Sciences and its competitors. For the Software industry, the median Equity-to-Asset is 0.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Earth Life Sciences's current Equity-to-Asset is 0.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Earth Life Sciences stock overvalued right now?
Earth Life Sciences (CLTS) has a current Equity-to-Asset of 0.91. The current Equity-to-Asset is 0.91 and 65.5% above the Software industry median of 0.55. Earth Life Sciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Earth Life Sciences (CLTS), the current Equity-to-Asset is 0.91 as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Earth Life Sciences Inc offers Artificial Intelligence (AI)-driven mileage-based loyalty system for public transportation. The Miltean's AI platform enables an increase of ridership, decongestion analysis, interruption of service compensation, congestion management, prediction and analysis of ridership usage patterns. The firm caters to public traffic management systems and team up relationships between private and public enterprise.
12GF Score
Get the complete analysis for CLTS
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLTS has been successfully added to your 
